Abstract
Glioma invasion into the CNS involves the interaction of tumor cells with the host’s cells and extracellular matrix (ECM) molecules. In this study, the expression of ECM-associated and cell-associated proteins such as the transmembrane CD44 adhesion molecule and neuro-glial proteoglycan 2 (NG2), a member of the chondroitin sulfate proteoglycan family, were evaluated during glioma progression, in vitro and in vivo, using a model of a highly invasive and aggressive intracerebral mouse G-26 glioma. We found a marked increase in CD44 and NG2 expression in brain tissue containing glioma. The glioma levels of these proteins gradually increased over time to reach 3–15 times the levels in the contralateral control. NG2 and CD44 expression paralleled progression of the glioma, being higher on days 14 and 21 than on day 2 post-glioma implant. In addition, when invading glioma crossed the midline in the advanced tumor stage, levels of each of these proteins in the contralateral tissue were elevated, but were still significantly lower than in the ipsilateral, tumor-bearing hemisphere. Immunohistochemistry of advanced stage G-26 glioma (day 21) showed CD44 expression to be most prominent at the front of the glioma invasion line, sharply separated from normal brain parenchyma which expressed glial fibrillary acidic protein (GFAP). However, single CD44 positive cells that escaped the tumor mass penetrated between the astrocytes that encased the tumor at its periphery. In contrast, NG2 was expressed on nearly all glioma cells within the tumor mass but less so at the leading edge of the tumor. The NG2 positive cells were clearly demarcated and morphologically distinguishable from GFAP positive cells and only sporadic, small groups of NG2 positive cells were seen in the GFAP positive zone of the neuropil. Taken together, these data show that during glioma progression in the brain, the level and pattern of glioma-associated molecules such as CD44 and NG2 may aid in tracing and targeting the invading glioma cells.
Similar content being viewed by others
References
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983–3988
Ariza, A., Lopez, D., Mate, J. L., Isamat, M., Musulen, E., Pujol, M., Levy, A., and Navas-Palacios, J. J. (1995). Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: An immunohistochemistry study. Human Pathol. 26, 1144–1147
Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C., and Van Meir, E. G. (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36, 1046–1069
Burg, M. A., Grako, K. A., and Stallcup W. B. (1998). Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J. Cell. Physiol. 177, 299–312
Burg, M. A., Nishiyama, A., and Stallcup, W. B. (1997). A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp. Cell Res. 235, 254–264
Butt, A. M., Kiff, J., Hubbard, P., and Berry, M. (2002). Synantocytes: New functions for novel NG2 expressing glia. J. Neurocytol. 31, 551–565
Chekenya, M., and Pilkington, G. J. (2002). NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumors. J. Neurocytol. 31, 507–521
Chekenya, M., Rooprai, H. K., Davies, D., Levine, J. M., Butt, A. M., and Pilkington, G. J. (1999). The NG2 chondroitin sulfate proteoglycan: Role in malignant progression of human brain tumors. Int. J. Dev. Neurosci. 17, 421–435
Chintala, S. K., Sawaya, R., Gokaslan, Z. L., Fuller, G., and Rao, J. S. (1996). Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett. 101, 107–114
Chittajallu, R., Aguirre, A., and Gallo, V. (2004). NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J. Physiol. 561, 109–122
Doane, K. J., Howell, S. J., and Birk, D. E. (1998). Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest. Ophthalmol. Visual Sci. 39, 263–275
Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema, T. R., Couchman, J. R., and McCarthy, J. B. (1992). A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116, 521–531
Fang, X., Burg, M. A., Barritt, D., Dahlin-Huppe, K., Nishiyama, A., and Stallcup, W. B. (1999). Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol. Biol. Cell 10, 3373–3387
Fidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., Faissner, A., and Fawcett, J. W. (1999). Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: The major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19, 8778–8788
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., and Vescovi, A. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011–7021
Gladson, C. L. (1999). The extracellular matrix of gliomas: Modulation of cell function. J. Neuropathol. Exp. Neurol. 10, 1029–1040
Hibino S., Shibuya, M., Engbring, J. A., Mochizuki, M., Nomizu, M., and Kleinman, H. K. (2004). Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res. 64, 4810–4816
Hibino S, Shibuya, M., Hoffman, M. P., Engbring, J.A., Hossain, R., Mochizuki, M., Kudoh, S., Nomizu, M., and Kleinman, H. K. (2005). Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res. 65, 10494–10501
Johansson, F. K., Goransson, H., and Westermark, B. (2005). Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24, 3896–3905
Jones, L. L., Yamaguchi, Y., Stallcup, W. B., and Tuszynski, M. (2002). NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22, 2792–2803
Kawashima, H., Hirose, M., Hirose, J., Nagakubo, D., Plaas, A. H. K., and Miyasaka, M. (2000). Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275, 35448–35456
Khoshyomn, S., Penar, P. L., Wadsworth, M. P., and Taatjes, D. J. (1997). Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy. Ultrastract. Pathol. 21, 517–525
Kim, M.-S., Park, M.-J., Moon, E.-J., Kim, S.-J., Lee, C.-H., Yoo, H., Shin, S.-H., Song, E.-S., and Lee, S.-H. (2005). Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-Kinase/Akt pathway to enhance motility of human glioma cells. Cancer Res. 65, 686–691
Knott, J. C., Mahesparan, R., Garcia-Cabrera, I., Bolge Tysnes, B., Edvardsen, K., Ness, G. O., Mork, S., Lund-Johansen, M., and Bjerkvig, R. (1998). Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int. J. Cancer 75, 864–872
Knutson, J. R., Iida, J., Fields, G. B., and McCarthy, J. B. (1996). CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell 7, 383–396
Levine, J. M. (1994). Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14, 4716–4730
Levine, J. M., and Card, J. P. (1987). Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: Association with smooth protoplasmic astrocytes. J. Neurosci. 7, 2711–2720
Levine, J. M., and Nishiyama, A. (1996). The NG2 chondroitin sulfate proteoglycan: A multifunctional proteoglycan associated with immature cells. Prespects Dev. Biol. 3, 245–259
Li, H., Liu, J., and Hofmann, M. (1995). Differential CD44 expression patterns in primary brain tumors and brain metastases. Br. J. Cancer 72, 160–163
Lin, H.-X., Dahlin-Huppe, K., and Stallcup, W. B. (1996a). Interaction of the NG2 proteoglycan with the actin cytoskeleton. J. Cell Biochem. 63, 463–477
Lin, X.-H., Grako, K. A., Burg, M. A., and Stallcup, W. B. (1996b). NG2 proteoglycan and the actin binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration. Mol. Biol. Cell 7, 1977–1993
Mahesparan, R., Read, T.-A., Lund-Johansen, M., Skaftnesmo, K. O., Bjerkvig, R., and Engebraaten, O. (2003). Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol. 105, 49–57
McKeever, P. E., Fligliel, S. E., Varani, J., Hudson, J. L., Smith, D., Castle, R. L., and McCoy, J. P. (1986). Products of cells cultured from gliomas. IV. Extracellular matrix proteins of gliomas. Int. J. Cancer 37, 867–874
Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., and Miyasaka, M. (2004). Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem. 279, 4541–4550
Nishiyama, A., Lin, X.-H., Giese, N., Heldin, C. H., and Stallcup, W. B. (1996). Co-localization of NG2 proteoglycan and PDGF alpha receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. 43, 299–314
Nishiyama, A., and Stallcup, W. B. (1993). Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol. Biol. Cell 4, 1097–1108
Pedersen, P. H., Marienhagen, K., Mork S., and Bjerkvig, R. (1993). Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res. 53, 5158–5165
Radotra, B., McCormick D., and Crockard, A. (1994). CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol. Appl. Neurobiol. 20, 399–405
Ranuncolo, S. M., Ladeda, V., Specterman, S., Varela, M., Lastiri, J., Morandi, A., Matos, E., Bal de Kier Joffe, E., Puricelli, L., and Pallotta, M. G. (2002). CD44 expression in human gliomas. J. Surg. Oncol. 79, 30–36
Rezajooi, K., Pavlides, M., Winterbottom, J., Stallcup, W. B., Hamlyn, P. J., Lieberman, A. R., and Anderson, P. N. (2004). NG2 proteoglycan expression in the peripheral nervous system: Upregulation following injury and comparison with CNS lesions. Mol. Cell. Neurosci. 25, 572–584
de Ridder, L. I., Laerum, O. D., Mork, S. J., and Bigner, D. D. (1987). Invasiveness of human glioma cell lines in vitro: Relation to tumorigenicity in athymic mice. Acta Neuropathol. 72, 207–213
Rutka, J. T., Ackerley, C., Hubbard, S. L., Tilup, A., Dirks, P. B., Jung, S., Ivanchuk, S., Kurimoto, M., Tsugu, A, and Becker, L. E. (1998). Characterization of glial filament-cytoskeletal interactions in human astrocytomas: An immuno-ultrastructural analysis. Eur. J. Cell Biol. 76, 279–287
Schrappe, M., Klier, G. F., Spiro, R. C., Waltz, T. A., Reisfeld, R. A., Gladson, C. L. (1991). Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res. 51, 4986–4993
Shoshan, Y., Nishiyama, A., Chang, A., Mork, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., and Staugaitis, S. M. (1999). Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors. Proc. Natl. Acad. Sci. USA 96, 10361–10366
Stallcup, W. B., Beasley, L., and Levine, J. M. (1983). Cell-surface molecules that characterize different stages in the development of cerebral interneurons. Cold Spring Harbor Symp. Quant. Biol. 48, 761–774
Stallcup, W. B., Dahlin, K., and Healy, P. (1990). Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J. Cell Biol. 111, 3177–3188
Stylli, S. S., Kaye, A. H., and Novak, U. (2000). Induction of CD44 expression in stab wounds of brain: Long term persistence of CD44 expression. J. Clin. Neurosci. 7, 137–140
Tillet, E., Gential, B., Garrone, R., and Stallcup, W. B. (2002). NG2 proteoglycan mediates beta 1 integrin-independent cell adhesion and spreading on collagen VI. J. Cell Biochem. 86, 726–736
Tysnes, B. B., Mahesparan, R., Thorsen, F., Haugland, H. K., Porwol, T., Enger, P. O., Lund-Johansen, M., and Bjerkvig, R. (1999). Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int. J. Dev. Neurosci. 17, 531–539
Wiranowska, M., Gonzalvo, A. A., Saporta, S., Gonzalez O. R., and Prockop, L. D. (1992). Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model. J. Neuro-Oncol. 14, 225–236
Wiranowska, M., and Naidu, A. K. (1994). Interferon effect on glycosaminoglycans in mouse glioma in vitro. J. Neuro-Oncol. 18, 9–17
Wiranowska, M, Prockop, L. D., Naidu, A. K., Saporta, S., Kori, S., and Kulkarni, A. (1994). Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity. Anticancer Res. 14, 1121–1126
Wiranowska, M., Rojiani, A., Gottschall, P., Moscinski, L., Johnson, J., and Saporta, S. (2000). CD44 expression and MMP-2 secretion by glioma cells: Effect of interferon and anti-CD44 antibody. Anticancer Res. 20, 4301–4306
Wiranowska, M., Tresser, N., and Saporta, S. (1998). The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro. Anticancer Res. 18, 3331–3338
Yamaguchi, Y. (2000). Lecticans: Organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57, 276–289
Yuan, W., Matthews, R. T., Sandy, J., and Gottschall, P. E. (2002). Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainic acid treated rats. Neurosicience 114, 1091–1101
Zheng, Z., Katoh, S., He, Q., Oritani, K., Miyake, K., Lesley, J., Hyman, R., Hamik, A., Parkhouse, R. M., Farr, A. G., and Kincade, P. W. (1995). Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130, 485–495.
Acknowledgment
This study was supported by a grant from the American Cancer Society Florida Division.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiranowska, M., Ladd, S., Smith, S.R. et al. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Bio 35, 159–172 (2006). https://doi.org/10.1007/s11068-007-9009-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11068-007-9009-0